Incidence, features, and outcomes of cytomegalovirus DNAemia in unmanipulated haploidentical allogeneic hematopoietic stem cell transplantation with post-transplantation cyclophosphamide.
Dixie HuntleyEstela GiménezMaría Jesús PascualJuan Carlos Hernández-BoludaBeatriz GagoLourdes VázquezJosé Luis PiñanaMagdalena GarcíaAriadna PérezDavid SerranoMarta HernándezEliseo AlbertCarlos SolanoDavide NavarroPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2019)
The incidence of initial and recurrent episodes of CMV DNAemia either requiring or not antiviral therapy in unmanipulated haplo-HSCT was comparable to other transplant modalities in our cohort.
Keyphrases
- allogeneic hematopoietic stem cell transplantation
- risk factors
- acute myeloid leukemia
- acute lymphoblastic leukemia
- stem cell transplantation
- low dose
- high dose
- bone marrow
- epstein barr virus
- cell therapy
- peripheral blood
- stem cells
- skeletal muscle
- hematopoietic stem cell
- adipose tissue
- cord blood
- replacement therapy